{
  "title": "Russia's Sputnik V vaccine is 91.6% effective against symptomatic Covid-19, interim trial results suggest",
  "link": "https://news.google.com/__i/rss/rd/articles/CBMiTmh0dHBzOi8vd3d3LmNubi5jb20vMjAyMS8wMi8wMi9oZWFsdGgvcnVzc2lhLXNwdXRuaWstdi1waGFzZS0zLWludGwvaW5kZXguaHRtbNIBUmh0dHBzOi8vYW1wLmNubi5jb20vY25uLzIwMjEvMDIvMDIvaGVhbHRoL3J1c3NpYS1zcHV0bmlrLXYtcGhhc2UtMy1pbnRsL2luZGV4Lmh0bWw?oc=5",
  "pubDate": "Tue, 02 Feb 2021 13:16:00 GMT",
  "source": "CNN",
  "content": "<ol><li><a href=\"https://news.google.com/__i/rss/rd/articles/CBMiTmh0dHBzOi8vd3d3LmNubi5jb20vMjAyMS8wMi8wMi9oZWFsdGgvcnVzc2lhLXNwdXRuaWstdi1waGFzZS0zLWludGwvaW5kZXguaHRtbNIBUmh0dHBzOi8vYW1wLmNubi5jb20vY25uLzIwMjEvMDIvMDIvaGVhbHRoL3J1c3NpYS1zcHV0bmlrLXYtcGhhc2UtMy1pbnRsL2luZGV4Lmh0bWw?oc=5\" target=\"_blank\">Russia's Sputnik V vaccine is 91.6% effective against symptomatic Covid-19, interim trial results suggest</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">CNN</font></li><li><a href=\"https://news.google.com/__i/rss/rd/articles/CBMijgFodHRwczovL3d3dy53c2ouY29tL2FydGljbGVzL3J1c3NpYW4tY292aWQtMTktdmFjY2luZS13YXMtaGlnaGx5LWVmZmVjdGl2ZS1pbi10cmlhbC1zdHVkeS1maW5kcy1ib29zdGluZy1tb3Njb3dzLXJvbGxvdXQtYW1iaXRpb25zLTExNjEyMjY5MDQ30gEA?oc=5\" target=\"_blank\">Russian Covid-19 Vaccine Was Highly Effective in Trial, Study Finds, Boosting Moscow’s Rollout Ambitions</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">The Wall Street Journal</font></li><li><a href=\"https://news.google.com/__i/rss/rd/articles/CBMib2h0dHBzOi8vd3d3LmNuYmMuY29tLzIwMjEvMDIvMDIvc3B1dG5pay12LXZhY2NpbmUtOTFwb2ludDZwZXJjZW50LWVmZmVjdGl2ZS1pbi1sYXRlLXN0YWdlLXRyaWFsLXRoZS1sYW5jZXQuaHRtbNIBc2h0dHBzOi8vd3d3LmNuYmMuY29tL2FtcC8yMDIxLzAyLzAyL3NwdXRuaWstdi12YWNjaW5lLTkxcG9pbnQ2cGVyY2VudC1lZmZlY3RpdmUtaW4tbGF0ZS1zdGFnZS10cmlhbC10aGUtbGFuY2V0Lmh0bWw?oc=5\" target=\"_blank\">Russia's Sputnik V vaccine 91.6% effective in late-stage trial</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">CNBC</font></li><li><a href=\"https://news.google.com/__i/rss/rd/articles/CBMiP2h0dHBzOi8vd3d3LmZ0LmNvbS9jb250ZW50LzExODBkMjRlLWVlYWYtNDMxNi1hNTA3LTMxMDhiYmE1MmMyONIBP2h0dHBzOi8vYW1wLmZ0LmNvbS9jb250ZW50LzExODBkMjRlLWVlYWYtNDMxNi1hNTA3LTMxMDhiYmE1MmMyOA?oc=5\" target=\"_blank\">Russia’s Sputnik vaccine shows 91.6% efficacy in clinical trials</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Financial Times</font></li><li><a href=\"https://news.google.com/__i/rss/rd/articles/CBMiYGh0dHBzOi8vd3d3LmJ1c2luZXNzaW5zaWRlci5jb20vcnVzc2lhLWNvcm9uYXZpcnVzLXZhY2NpbmUtcGhhc2UtMy1pbnRlcmltLXJlc3VsdHMtbGFuY2V0LTIwMjEtMtIBZGh0dHBzOi8vd3d3LmJ1c2luZXNzaW5zaWRlci5jb20vcnVzc2lhLWNvcm9uYXZpcnVzLXZhY2NpbmUtcGhhc2UtMy1pbnRlcmltLXJlc3VsdHMtbGFuY2V0LTIwMjEtMj9hbXA?oc=5\" target=\"_blank\">Russia coronavirus vaccine 91.6% effective: Lancet - Business Insider</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Business Insider</font></li><li><strong><a href=\"https://news.google.com/stories/CAAqOQgKIjNDQklTSURvSmMzUnZjbmt0TXpZd1NoTUtFUWpZbTZEc2tZQU1FVXRWY2N3YlpVSkdLQUFQAQ?oc=5\" target=\"_blank\">View Full Coverage on Google News</a></strong></li></ol>",
  "contentSnippet": "Russia's Sputnik V vaccine is 91.6% effective against symptomatic Covid-19, interim trial results suggest  CNN\nRussian Covid-19 Vaccine Was Highly Effective in Trial, Study Finds, Boosting Moscow’s Rollout Ambitions  The Wall Street Journal\nRussia's Sputnik V vaccine 91.6% effective in late-stage trial  CNBC\nRussia’s Sputnik vaccine shows 91.6% efficacy in clinical trials  Financial Times\nRussia coronavirus vaccine 91.6% effective: Lancet - Business Insider  Business Insider\nView Full Coverage on Google News",
  "guid": "27ac182c1ba36b0a3b53d1587e1ea7b4",
  "isoDate": "2021-02-02T13:16:00.000Z",
  "original_created_at": "2021-02-02T13:16:00.000Z",
  "created_at": "2021-02-02T15:02:46.602Z",
  "original_guid": "52781348556248",
  "id": "27ac182c1ba36b0a3b53d1587e1ea7b4",
  "tags": [
    "CNN"
  ],
  "image": "https://cdn.cnn.com/cnnnext/dam/assets/210202055110-sputnik-v-coronavirus-vaccine-russia-trial-super-tease.jpg",
  "localize": [
    {
      "locale": "zh",
      "title": "中期试验结果显示，俄罗斯的斯普特尼克五型疫苗对症状性科威德-19的有效率为91.6%。"
    },
    {
      "locale": "zh-Hant",
      "title": "中期試驗結果顯示，俄羅斯的斯普特尼克五型疫苗對症狀性科威德-19的有效率爲91.6%。"
    }
  ]
}